Saturday, 3 October 2026Updated 19m ago
← Top stories
● Neutral for Sun Pharma

Sun Pharma's Leqselvi shows sustained hair regrowth through two years in alopecia areata

1 source · first seen 22:29 2 Oct · updated 22:29 2 Oct

Tags on this story

Pick a tag to see all its stories
Sun Pharma₹1,801.00 · 1 todayPharma and healthcare14 today

Linked by the tag Sun Pharma

14 stories this week
  1. 29 SeptExpanding innovative portfolio may drive gains for Sun Pharma stockBroker call · 1 source · Lerodalcibep licensing, US portfolio growth and tariff relief are cited as potential stock drivers
  2. 29 SeptSun Pharma Plans Rs 10,000 Crore Rupee Debt Sale To Refinance Organon Deal: ReportFunding and debt · 2 sources · Sun Pharma plans a ₹10,000 crore bond sale to refinance its Organon deal
  3. 29 SeptSun Pharma plans $1 billion local debt sale for loan takeout, sources sayFunding and debt · 3 sources · Sun Pharma plans to raise about ₹10,000 crore through rupee-denominated bonds
  4. 28 SeptUS exempts select Indian specialty drugs and ingredients from its 100% pharma tariffPolicy · 7 sources · The exemption covers certain specialty drugs and ingredients from India and 19 other countries
  5. 28 SeptSun Pharma secures rights to commercialise Lerodalcibep outside the US and ChinaDeal · 8 sources · Sun Pharma will commercialise and manufacture Lerodalcibep worldwide, excluding the United States and China
All Sun Pharma stories →

Read the reports

1 report · earliest 22:29
The Pharma LetterSun Pharma's Leqselvi shows sustained hair regrowth through two years in alopecia areata22:29